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Abstract: Astaxanthin is one of the strongest natural antioxidants and a red pigment occurring in
nature. This C40 carotenoid is used in a broad range of applications such as a colorant in the feed
industry, an antioxidant in cosmetics or as a supplement in human nutrition. Natural astaxanthin
is on the rise and, hence, alternative production systems are needed. The natural carotenoid
producer Corynebacterium glutamicum is a potent host for industrial fermentations, such as million-ton
scale amino acid production. In C. glutamicum, astaxanthin production was established through
heterologous overproduction of the cytosolic lycopene cyclase CrtY and the membrane-bound
β-carotene hydroxylase and ketolase, CrtZ and CrtW, in previous studies. In this work, further
metabolic engineering strategies revealed that the potential of this GRAS organism for astaxanthin
production is not fully exploited yet. It was shown that the construction of a fusion protein
comprising the membrane-bound β-carotene hydroxylase and ketolase (CrtZ~W) significantly
increased astaxanthin production under high glucose concentration. An evaluation of used carbon
sources indicated that a combination of glucose and acetate facilitated astaxanthin production.
Moreover, additional overproduction of cytosolic carotenogenic enzymes increased the production of
this high value compound. Taken together, a seven-fold improvement of astaxanthin production was
achieved with 3.1 mg/g CDW of astaxanthin.
Keywords: astaxanthin; Corynebacterium glutamicum; fusion protein; β-carotene ketolase;
β-carotene hydroxylase
1. Introduction
The demand for naturally produced astaxanthin is estimated to witness an exponential growth
of 25% (CAGR) by 2025 [1]. This fact is in accordance with a worldwide trend: consumers seek for
natural products that are produced in an environmentally friendly way. Moreover, the feed industry,
which is the main purchaser of astaxanthin, is growing as well in order to satisfy the demand for
animal-based food products such as meat, fish and eggs [2]. As the astaxanthin market is dominated by
synthetic astaxanthin that is made from petro chemistry, new production capacities are needed to meet
the increasing demand for naturally produced astaxanthin [1]. Fermentations with Corynebacterium
glutamicum dominate food and feed biotechnology since decades for the production of amino acids e.g.
l-glutamate and l-lysine [3–5]. This microorganism naturally synthesizes carotenoids as pigments and
yet investigations concerning this output are limited. The carotenoid/terpenoid precursors dimethylallyl
pyrophosphate (DMAPP) and isopentenyl pyrophosphate (IPP) are derived from the MEP-pathway in
this organism [6]. Carotenoid biosynthesis of the natural C50 carotenoid decaprenoxanthin is based
on the accumulation of the C40 intermediate lycopene [7,8]. The genome of C. glutamicum contains
Mar. Drugs 2019, 17, 621; doi:10.3390/md17110621 www.mdpi.com/journal/marinedrugs
Mar. Drugs 2019, 17, 621 2 of 12
a major carotenoid operon [9] and the regulatory mechanism involving a MarR-type transcriptional
regulator CrtR was identified [10]. Interestingly, this regulation is working in a metabolite dependent
manner in which the carotenoid precursor molecule geranylgeranyl pyrophosphate (GGPP) is acting
as an effector of the repressor CrtR [10]. Thus, as the genetic background was analyzed in more
detail, the production of industrially relevant carotenoids of the C40 family was conducted over the
last years [6,7,11] (Figure 1). Indeed, metabolic engineering studies showed that C. glutamicum is
a suitable host for production of various C40 and C50 carotenoids [11,12] with astaxanthin as prominant
example [13]. The previously published strain ASTA1 possesses a good volumetric productivity, but for
industrial scale production further improvement is needed in order to meet economically feasible
production titers.
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Figure 1. Astaxanthin biosynthesis in engineered C. glutamicum. Astaxanthin biosynthesis with 
DMAPP (dimethylallyl pyrophosphate) and IPP (isopentenyl pyrophosphate) as precursors involves 
seven enzymes: endogenous Idi: isopentenyl pyrophosphate isomerase, IdsA: GGPP synthase, CrtB: 
phytoene synthase and CrtI: phytoene desaturase; as well as heterologous CrtY: lycopene cyclase, 
CrtW: β-carotene ketolase and CrtZ: β-carotene hydroxylase. 
The construction of fusion proteins and the application of membrane anchors was shown to be 
an efficient strategy to increase membrane integrity and protein stability. It was shown that linkage 
of CrtW and CrtZ with the GlpF protein from E. coli increased astaxanthin production by 
approximately 2-fold [14]. Moreover, the fusion of a geranylgeranyl pyrophosphate synthase with a 
phytoene synthase improved carotenoid production in plant cells [15]. Recently, it was shown that 
fusion of the terminal carotenoid enzymes increased astaxanthin production in E. coli [16]. 
In this study, a fusion protein strategy was conducted (Figure 2) that resulted in an 
approximately five-fold improved astaxanthin production under high glucose concentration in C. 
glutamicum. Moreover, it turned out that the co-utilization of glucose and potassium acetate 
significantly improved astaxanthin production in small-scale fermentations. Thus, not only classical 
metabolic engineering strategies, but also the construction of fusion proteins and the optimization of 
cultivation media are powerful strategies to exploit the potential of valuable compound formation.  
  
Figure 1. Astax nthin biosynthesis n engineered C. glutamicum. Astax nthin biosynthesis with
DMAPP (dimethylal y pyrophosphate) and IPP (isopentenyl pyrophosphate) as precursors involves
sev n enzymes: endogenous Idi: isopentenyl pyrophosphate isomerase, IdsA: G PP synthase, CrtB:
phytoene synthase and CrtI: phytoene desaturase; as well as heterologous CrtY: lycopene cyclase, CrtW:
β-ca otene ket las and CrtZ: β-carotene hydroxylase.
The construction of fusion proteins and the application of membrane anchors was shown to be
an efficient strategy to increase me brane integrity and protein stability. It was shown that linkage of
CrtW and CrtZ with the GlpF protein from E. coli increased astaxanthin production by a proximately
2-fold [14]. Moreover, the fusion of a geranylgeranyl pyrophosphate synthase with a phytoene synthase
im roved carotenoid production in pla t cells [15]. Recently, it was shown that fusion of the terminal
carotenoid enzymes increased astaxa thin production in E. coli [16].
In this study, a fusion protein strategy was conducted (Figure 2) that resulted in an approximately
five-fold i proved astaxanthin production under high glucose concentration in C. glutamicum.
Moreover, it turned out that the co-utilization of glucose and potassium acetate significantly improved
astaxanthi production in small-scale fermentatio s. Thus, not only classical metabolic engineering
strategies, but also the construction of fusi n proteins and the optimization of cultivati n media are
powerful strategies to ex loit the potential of valuable compound formation.
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2. Results
2.1. Fusion of the Membrane-bound Proteins β-carotene Hydroxylase and β-carotene Hydroxylase Increased
Astaxanthin Production under High Glucose Concentration
Previous studies have shown that astaxanthin biosynthesis in engineered C. glutamicum
strains is limited by the conversion of β-carotene to astaxanthin and/or the overall flux towards
carotenoid products [13]. The previously constructed ASTA1 strain that carries the expression vectors
pSH1-crtW and pECXT-crtZ yielded astaxanthin as the major carotenoid product under low glucose
concentration [13] as shown in Figure 3. However, it turned out that the astaxanthin production in
this strain is not robust to higher glucose concentration (Figure 3). Since β-carotene accumulated,
it is tempting to speculate that the two functionalizing enzymes CrtW and CrtZ are limiting under
such cultivation conditions, which are favorable for industrial applications in order to achieve high
cell densities.
Both enzymes,β-carotene hydroxylase andβ-carotene ketolase, are predicted to be transmembrane
enzymes with three (CrtZ) and five (CrtW) putative transmembrane helices [17]. As heterologous
overproduction of transmembrane enzymes is critical, here a transcriptional and a translational
fusion strategy approach were applied in order to facilitate protein stability, membrane integrity
and intermediate channeling. The construction of artificial operon crtW→Z and crtZ→W yielded
astaxanthin production whereas the crtZ→W construct already doubled astaxanthin production under
high glucose concentration (Figure 3). Moreover, the two enzymes CrtW and CrtZ were translationally
fused with an artificial ten amino acid linker sequence (GGGGSGGPGS) and in both sequential orders
(Figure 2). It turned out that the protein fusion CrtW~Z did not result in astaxanthin production
presumably due to an inactive fusion enzyme. In contrast, a functional CrtZ~W fusion protein resulted
in an about five-fold increased astaxanthin accumulation in comparison to the two-vector system in
ASTA1 (Figures 2 and 3).
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identical synthetic linker sequence of 10 amino acids (GGGGSGGPGS). 
All constructed one-vector systems, including the fusion proteins were cultivated under low 
(2%) and high (4%) glucose concentration and compared to the previously published two-vector 
system. Under low glucose concentration, the two-vector system pSH1-crtW & pECXT-crtZ yielded 
the highest astaxanthin titer of 8.6 mg/L (1.3 mg/g CDW). Concerning the one-vector system, all 
constructs yielded astaxanthin accumulation except for the fusion protein construct pSH1-crtW~Z 
(Figure 3). However, under this condition all newly constructed strains resulted in a decreased 
Figure 2. Scheme of newly constructed fusion proteins CrtW~Z (A) and CrtZ~W (B). Transmembrane
helices were predicted with TMHMM [17]. CrtW comprises 5 TMH with an intracellular N-terminus;
CrtZ comprises 3 TMH with an extracellular N-terminus; both fusions contained an identical synthetic
linker sequence of 10 amino acids (GGGGSGGPGS).
All constructed one-vector systems, including the fusion proteins were cultivated under low
(2%) and high (4%) glucose concentration and compared to the previously published two-vector
system. Under low glucose concentration, the two-vector system pSH1-crtW & pECXT-crtZ yielded the
highest astaxanthin titer of 8.6 mg/L (1.3 mg/g CDW). Concerning the one-vector system, all constructs
yielded astaxanthin accumulation except for the fusion protein construct pSH1-crtW~Z (Figure 3).
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However, under this condition all newly constructed strains resulted in a decreased astaxanthin titer
when compared to the two-vector system. However, under high glucose concentration, which is
favorable for industrial applications to yield high biomass titers, the two-vector system yielded only
50% of the astaxanthin compared to the low glucose concentration (Figure 3). However, the one vector
system comprising the transcriptional fusion of crtZ and crtW resulted in increased astaxanthin titers
as the transcriptional fusion strain BETA4 (pSH1-crtZ-crtW) produced 11 mg/L (0.42 mg/g CDW)
astaxanthin. Moreover, the translation fusion strain BETA4 (pSH1-crtZ~W) was the best strain as
it produced 22 mg/L (1.7 mg/g CDW) of astaxanthin, which was almost five-fold better than the
two-vector system (Figure 3). This strain was named ASTA*. Thus, it turned out that the fusion protein
strategy considerably affected the astaxanthin titer under high glucose concentration in fermentations
of C. glutamicum strains.
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Figure 3. Production profiles of engineere . t i s for astaxanthin production under (A)
low (2%) and (B) high (4%) glucose concentra ion. Product ti ers (in mg/L) were d termined from three
biological triplicates after cultivation f r 48 h in biolector microcultivation system.
2.2. Overproduction of Cytosolic Carotenoid Enzymes Increased Astaxanthin Production under High
Glucose Concentration
As the strain ASTA* produced astaxanthin as the dominant carotenoid under high glucose
concentration (Figure 3), but did not reach maximal β-carotene titers, other upstream working enzymes
of the carotenoid pathway may have limited astaxanthin production under these conditions. Therefore,
it was tested whether other carotenogenic enzyme(s) limit the flux towards astaxanthin in the newly
constructed ASTA* strain. Hence, the genes idi, idsA and crtBI coding for isopentenyl pyrophosphate
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isomerase, GGPP synthase, phytoene synthase and phytoene desaturase were overexpressed in ASTA*.
As shown in Figure 4, the astaxanthin content slightly increased in all constructed strains. However,
only combined overexpression of all tested genes (idi, idsA and crtBI) or of phytoene synthase and
desaturase genes (crtBI) significantly increased the astaxanthin titer to 2.25 ± 0.06 mg/g CDW, which is
about 25% more than the production of the control strain (1.8± 0.1 mg/g CDW) (Figure 4). Thus, it could
be shown that overexpression of genes encoding for upstream and cytosolic carotenoid biosynthesis
affected astaxanthin production positively and represent new targets for chromosomal engineering of
the platform strain.
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Figure 4. Effect of overexpression of genes for cytosolic carotenoid biosynthesis enzymes in C. glutamicum
ASTA*. Astaxanthin (red) and β-carotene (grey) content is given in mg/g CDW from 48 h cultivations
in CGXII medium with 4% glucose from biolector microcultivation system. Mean values and standard
deviations are given. Significance was calculated with a students’ t-test, p < 0.05.
2.3. Co-utilization of Glucose and Potassium Acetate Improved Astaxanthin Production in Minimal Medium
Based on our findings on engineering carotenogenesis downstream of the central precursors
IPP and DMAPP, we postulated that the overall bottleneck for astaxanthin production in the ASTA*
strain might be the central carbon fluxes and not only the expression of carotenogenic genes. Since the
MEP pathway draws pyruvate and GAP from glycolysis and since it is known that during growth on
mixtures of glucose and potassium acetate the C. glutamicum cell accumulates glycolytic intermediates
to higher concentrations [18], a cultivation using a blend of the two carbon sources glucose and
potassium acetate was performed (Figure 5). Indeed, it could be shown that addition of up to 2%
potassium acetate in the CGXII medium together with 4% glucose significantly increased the overall
production titer. Under conditions were 4% glucose and 2% acetate were utilized the maximal titer of
3.11 ± 0.2 mg/g CDW astaxanthin were reached which is 80% more than the production from glucose
as sole carbon source (1.72 ± 0.18 mg/g CDW) (Figure 5). However, when the acetate concentration was
further increased to 4% and 6%, astaxanthin production significantly dropped to about 1 and < 1 mg/g
CDW, respectively (Figure 5).
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3. Discussion
In this work, astaxanthin production in C. glutamicum was improved through the application
of three different strategies, namely: construction of membrane fusion-proteins, overproduction of
cytosolic carotenoid biosynthesis enzymes and use of blends of glucose and potassium acetate as
fermentation substrates. Astaxanthin production with C. glutamicum is of high interest as this workhorse
is used in a safe manner for more than 60 years in the food and feed industry. Although C. glutamicum
can grow to high cell densities of up to 95 g/L [19,20], fermentation processes with C. glutamicum
for secreted product such as amino acids are characterized by a high proportion of substrate being
converted to product rather than to biomass [19]. It has been shown that C. glutamicum is a potent
host for high titer terpenoid production as maximal titers of 1.25 g/L of secreted isopentenol were
reached [21]. We have previously shown that multiple products can be coproduced, i.e., cell-bound
carotenoids with secreted amino acids [22]. However, lysine is not produced by wild type based
strains as the parental strain of this study (only the astaxanthin and lysine producing recombinant
ASTALYS produced lysine). Thus, we did not find lysine in supernatants of the astaxanthin producing
strains used here (data not shown). By contrast, glutamate production can be triggered in the wild
type. Glutamate could be coproduced with astaxanthin by recombinants based on wildtype [22].
Interestingly, some glutamate was produced by the astaxanthin strain ASTA1 even in the absence of
any trigger [22], which we could confirm here. The application of the fusion protein CrtZ~W resulted
in maximal glutamate titers of around 7 mM (data not shown), which are in accordance with previously
published data obtained with the ASTA1 strain [22].
The production process for astaxanthin, a cell-bound product, requires a high cell density
cultivation in order to reach economically feasible productivites. For this reason, the robustness of the
astaxanthin production under high glucose concentration was addressed with the first strategy: the
construction of the fusion protein CrtZ~W.
It was shown that the ASTA* strain with the fusion protein CrtZ~W performed robust in terms of
astaxanthin production titers of 4% glucose whereas the forerunner strain ASTA1 comprising single
enzymes CrtZ and CrtW did not perform well under such conditions. The explanation for this and
related findings on synthetic fusion proteins has not yet been analyzed well. However, it is typically
argued that fusion proteins, in a similar manner as application of protein scaffolds and colocalization in
compartments, result in an optimized transfer of intermediates between enzymes [23–25]. Application
of fusion proteins for carotenoid production has recently gained more interest. It has been shown that
application of a tridomain protein comprising CrtB, CrtI and CrtY doubled β-carotene production
by S. cerevisiae [26]. Both, the domain order and the linker properties, were claimed to influence
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the stability and/or expression of such enzymes [26]. Interestingly, the natural astaxanthin producer
Xanthophyllomyces dendrorhous possesses bifunctional enzymes in carotenogenesis. A fused phytoene
synthase-lycopene cyclase CrtYB is encoded in its genome as well as an astaxanthin synthase CrtS
that catalyses both ketolation and hydroxylation of β-carotene [27,28]. Moreover, application of such
natural or synthetic bifunctional enzymes has not only been proven to accelerate carotenoid production
in unicellular systems, but also in plants [29]. In addition, the fusion of a FPP synthase with a patchoulol
synthase also accelerated formation of the sesquiterpene patchoulol in yeast [30]. The CrtZ~W fusion
protein described here (Figure 2) was constructed with a Gly-Ser rich linker sequence. Such linkers are
generally regarded as flexible whereas amino acids Glu, Ala, Lys tend to build rigid linkers [31]. It has
to be examined how a rigid linker might influence the CrtZ~W fusion. Besides the flexibility also the
length of the linker sequence affects the activity of the enzymes. The ten amino acid linker used in this
study is regarded as medium sized, whereas 5 and 21 amino acid linker sequences may be categorized
as small and large, respectively [31,32]. Since it was shown that the optimal linker length relies on the
fused proteins themselves [16], it has to be validated in the future if shorter or longer linkers might
increase astaxanthin production catalyzed by the bifunctional CrtZ~W fusion further.
In contrast, changing the order of CrtW and CrtZ in the fusion protein did not lead to astaxanthin
production, which is most probably due to reduced β-carotene hydroxylase activity of the CrtW~Z
fusion protein since neither zeaxanthin nor astaxanthin were synthesized (Figure 3). However,
the strain with the CrtW~Z fusion protein produced about 62 mg/L of the precursor β-carotene,
which is less compared to about 85 mg/L produced by the parental strain BETA4 (data not shown).
Thus, we hypothesize that functional expression of crtW and/or crtZ limits carotenoid biosynthesis.
As in other recombinant microorganisms the molecular cause remains to be identified. Moreover,
the ketolase activity of fusion protein CrtW~Z might also be limiting in this fusion construct as only
minor amounts of canthaxanthin were identified (data not shown). Similarly, a recent study showed
that fusion proteins with CrtZ at the N-terminus are superior over N-terminal CrtW fusion proteins as
it was demonstrated for different bifunctional enzymes in E. coli [29] and Nicotiana benthamiana [16].
As an explanation the locatization of histidine motifs is discussed, as these are on the surface of active
CrtZ~W fusions, but are inside the inactive CrtW~Z fusion proteins [16]. For an algal β-carotene
ketolase it was shown that both N-terminal fusion of the signal peptide from OmpF and C-terminal
fusion of TrxA increased astaxanthin formation most likely by a better guiding of the protein to the
membrane (OmpF signal peptide) and increased protein stability (TrxA) [33].
The overexpression of cytosolic carotenoid biosynthesis genes only increased astaxanthin
production to a minor extent. However, the screening of potential bottleneck enzymes Idi, IdsA,
CrtB and CrtI from the upstream carotenoid biosynthesis pathway lead to the conclusion that astaxanthin
biosynthesis in ASTA* can be increased by overexpression of crtBI in particular. It is known from a wide
number of publications that the carbon source significantly influences the overall metabolic flux and
therefore affects product formation by C. glutamicum [18]. Glucose and acetate are typically co-utilized
in C. glutamicum as it was shown in previous studies [34]. Here, co-utilization of 4% glucose with 2%
acetate significantly increased astaxanthin titers to more than 3 mg/g CDW which is the highest titer for
this organism so far. This effect might be explained by altered concentrations of central metabolites such
as GAP and pyruvate, which are the substrates of the MEP-pathway in C. glutamicum. Alternatively,
as NAD(P)H and 2-oxoglutarate are believed to be cofactors or co-substrates for the ketolation and
hydroxylation reactions catalyzed by CrtW and CrtZ, their availability might be affected by the used
carbon source [35,36]. It was shown in E. coli that co-utilization of glycerol and glucose in a 4:1 ratio
is favorable for astaxanthin production over utilization glycerol alone [16]. It was hypothesized that
glycerol with a higher average degree of reduction per carbon can provide more reducing equivalents
for astaxanthin biosynthesis [16,33,37]. As it turned out that solely the carbon source composition
strongly affected astaxanthin production in C. glutamicum, further media optimization has to be
performed. The basic medium used in this study is the CGXII minimal medium which was initially
optimized for amino acid production with an elemental composition of C:N:P of 40:10:1 [38]. Thus,
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for the production of astaxanthin a DOE approach would be suitable to optimize the minimal medium
fundamentally. Moreover, it can be concluded that the potential of C. glutamicum has a host for
membrane-bound carotenoids is not fully tapped yet and that media composition as part of the process
design can make a significant contribution towards economically feasible product titers.
4. Materials and Methods
4.1. Bacterial Strains and Growth Conditions
Strains and plasmids used in this study are listed in Table 1. All production experiments were
carried out in the BETA4 platform strain [13] that was constructed on the basis of a prophage-cured
C. glutamicum MB001 [39]. Precultures of C. glutamicum strains were grown in complex medium Luria
Broth (LB) or Brain Heart Infusion (BHI) supplemented with 2% glucose over night. Main cultures
were grown in CGXII minimal medium supplemented with glucose and/or potassium acetate after
washing in the minimal medium. Each culture was inoculated to an initial OD600 of 1. Cultivations
were performed in 1 mL in the Biolector®flowerplate microcultivation system (m2p-labs GmbH,
Baesweiler, Germany) at 1100 rpm at 30 ◦C. E. coli DH5α cells were cultivated at 37 ◦C in LB medium.
Tetracycline and kanamycine were added if appropriate in concentrations of 5 and 25 µg mL−1.
Table 1. Strains and plasmids used in this study.
Strain Characteristics Reference
C. glutamicum strains
WT Wild type, ATCC 13032 [40]
MB001 prophage cured, genome reduced ATCC 13032 [39]
BETA4 MB001 derivative with deletion of crtYEb (cg0717-0719) and crtR (cg0725) andintegration of Ptuf-dxs, Ptuf-crtEBI, Ptuf -crtYPa
[13]
ASTA1 BETA4 derivative with pSH1-crtWFp and pECXT99A-crtZFp [13]
ASTA* BETA4 derivative with pSH1-crtZ~WFp This work
Other strains
E. coli DH5α F-thi-1 endA1 hsdr17(r-, m-) supE44 ∆lacU169 (Φ80lacZ∆M15) recA1 gyrA96 [41]
Pantoea ananatis Wild type, ATCC 33244, DSM 17873, Z96081 [42]
Fulvimarina pelagi Wild type, ATCC BAA-666, DSM 15513, AY178860 [43]
Plasmids
pECXT99A (pECXT) TetR, PtrclacIq, pGA1 oriVCg, C. glutamicum/E. coli expression shuttle vector [44]
pECXT-idi pECXT99A derivative for IPTG-inducible expression of idi (cg2531) This work
pECXT-idsA pECXT99A derivative for IPTG-inducible expression of idsA (cg2384) This work
pECXT- crtBI pECXT99A derivative for IPTG-inducible expression of crtBI (cg0721/0720) This work
pECXT-idi-idsA pECXT99A derivative for IPTG-inducible expression of idi (cg2531) and idsA (cg2384) This work
pECXT-idsA-crtBI pECXT99A derivative for IPTG-inducible expression of idsA (cg2384) and crtBI(cg0721/0720) This work
pECXT-idi-idsA-crtBI pECXT99A derivative for IPTG-inducible expression of idi (cg2531), idsA (cg2384)and crtBI (cg0721/0720) This work
pSH1 KmR, Ptuf, pHM519 oriVCg, C. glutamicum/E. coli expression shuttle vector [13]
pSH1-crtW-crtZ pSH1 derivative for constitutive expression of the artificial operon comprising crtWand crtZ from F. pelagi This work
pSH1-crtW~Z pSH1 derivative for constitutive expression of crtW~Z encoding for a fusion proteincomprising CrtW and CrtZ from F. pelagi This work
pSH1-crtZ-crtW pSH1 derivative for constitutive expression of the artificial operon comprising crtZand crtW from F. pelagi This work
pSH1-crtZ~W pSH1 derivative for constitutive expression of crtZ~W encoding for a fusion proteincomprising CrtZ and CrtW from F. pelagi This work
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4.2. Cloning of Expression Vectors
Expression plasmids were constructed in E. coli DH5α. First target genes were amplified by
a high-fidelity PCR (All-in HiFi, highQu, Kraichtal, Germany) and cloned into digested expression
vectors by Gibson-Assembly [45]. Used oligonucleotides are listed in Table 2 and were delivered by
Metabion (Planegg/Steinkirchen, Germany). PCR products were purified with PCR- and gel extraction
kit (Macherey-Nagel, Düren, Germany). E. coli DH5α cells were transformed by heat shock after
preparation of CaCl2 competent cells. Transformants were screened by colony-PCR and plasmids
were isolated by plasmid miniprep kit (GeneJET, Thermo Fisher Scientific, Schwerte, Germany).
New expression vectors were confirmed by sequencing. C. glutamicum cells were transformed by
electroporation as described elsewhere [46].
Table 2. Oligonucleotides used in this study.
Oligo-
nucleotide Target Sequence (5’→ 3’)
FpW1 Wfw1 CATGCCTGCAGGTCGACTCTAGAGGAAAGGAGGCCCTTCAGATGACCCTCAGCCCAACCTC
HN05 Wrv1 GTTCGTGTGGCAGTTTTAGGACTGGCGAGTATGCG
HN06 Zfw1 AACTGCCACACGAACGAAAGGAGGCCCTTCAGATGACGATCTGGACTCTCTACTAC
HA35 Zrv1 ATTCGAGCTCGGTACCCGGGGATCTTACCGAACCGGCGCGT
HA47 Wrv-L CGGAACCGCCACCGCCGGACTGGCGAGTATG
HA48 L-Zfw GGCGGTGGCGGTTCCGGCGGTCCAGGTTCCACGATCTGGACTCTCTACTAC
HA34 Zfw2 CATGCCTGCAGGTCGACTCTAGAGGAAAGGAGGCCCTTCAGATGACGATCTGGACTCTCTACTAC
HA45 Zrv2 GTTCGTGTGGCAGTTTTACCGAACCGGCGCGT
HA46 Wfw2 AACTGCCACACGAACGAAAGGAGGCCCTTCAGATGACCCTCAGCCCAACCTC
FpW4 Wrv2 ATTCGAGCTCGGTACCCGGGGATCTTAGGACTGGCGAGTATGCG
HA49 Zrv-L CGGAACCGCCACCGCCCCGAACCGGCGCGT
HA50 L-Wfw GGCGGTGGCGGTTCCGGCGGTCCAGGTTCCACCCTCAGCCCAACCTC
HA67 Idifw ATGGAATTCGAGCTCGGTACCCGGGGAAAGGAGGCCCTTCAGATGTCTAAGCTTAGGGGCATGAC
HA68 Idirv GCATGCCTGCAGGTCGACTCTAGAGGATCTTACTCTGCGTCAAACGCTTC
HA69 CrtBIfw ATGGAATTCGAGCTCGGTACCCGGGGAAAGGAGGCCCTTCAGATGACACACCAAAATTCGCC
HA70 CrtBIrv GCATGCCTGCAGGTCGACTCTAGAGGATCTTAATGATCGTATGAGGTCTTTTGAG
NH56 idsArv GCATGCCTGCAGGTCGACTCTAGAGGATCTTACATCCGACGTTCGGTTGA
NH55 idsAfw ATGGAATTCGAGCTCGGTACCCGGGGAAAGGAGGCCCTTCAGATGAGCAGTTTCGATGCCCA
NH57 idsA-rv-L GTTCGTGTGGCAGTTTTACATCCGACGTTCGGTTGA
HA71 L-CrtBIfw AACTGCCACACGAACGAAAGGAGGCCCTTCAGATGACACACCAAAATTCGCC
PD5 ACCGGCTCCAGATTTATCAG
582 ATCTTCTCTCATCCTCCA
pEC-fw AATACGCAAACCGCCTCTCC
4.3. Construction of pSH1- and pECXT99A-based Expression Vectors
For construction of expression plasmids pSH1 and pECXT99A vectors were digested with
BamHI (Thermo Scientific Fisher, Schwerte, Germany) and dephosphorylated (Antarctic phosphatase,
New England Biolabs, Frankfurt, Germany). PCR products were amplified using the oligonucleotides
as the following: crtW1: FpW1 + HN05; crtZ1: HN06 + HA35; crtW-L: FpW1 + HA47; L-crtZ:
HA48 + HA35; crtZ2: HA34 + HA45; crtW2: HA46 + FpW4; crtZ-L: HA34 + HA49; L-crtW: HA50
+ FpW4; idi: HA67 + HA68; crtBI: HA69 + HA70; idi-idsA: HA67 + NH56; idsA-L: NH55 + NH57;
L-crtBI: HA71 + HA70; idi-idsA-L: HA67 + NH57. All genes were cloned with their native ORF
sequences from gene donors. For transcriptional fusions of crtZ/crtW genes the artificial linker
sequence AACTGCCACACGAAC was used and the consensus ribosome binding sequence with
optimal spacing (GAAAGGAGGCCCTTCAG) was used for each gene. For pECXT99A derivatives,
15 bp artificial linker sequences were used and the consensus ribosome binding sequence with optimal
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spacing was inserted in front of idi, idsA, and crtBI. All relevant oligonucleotides used for cloning
are included in Table 2. PCR products were cloned into the digested vectors by Gibson method [45].
Colony-PCR was performed with standard vector oligonucleotides (pSH1: PD5 + 582; pECXT99A:
pEC-fw + 582).
4.4. Carotenoid Quantification
Carotenoid production was analyzed by HPLC analysis. First, carotenoids were extracted from the
cell fraction of the cultivation broth using a methanol:acetone (7:3) mixture. Extraction was performed
at 60 ◦C and 600 rpm for 15 min. After centrifugation at 14,000 rpm and 10 min the supernatant was
used for high performance liquid chromatography (HPLC). The Agilent 1200 series system (Agilent
Technologies, Waldbronn, Germany) was used with a reversed phase column system. Carotenoids
were detected with a diode array detector (DAD) through recording of the UV/visible (Vis) spectrum.
For quantification the extracted wavelength chromatogram at λmax 470 nm was used. Calibration curves
were generated with standard substances: β-carotene, canthaxanthin and astaxanthin (Sigma-Aldrich).
The column system consisted of a precolumn (LiChrospher 100 RP18 EC-5, 40 × 4 mm) and a main
column (LiChrospher 100 RP18 EC-5, 125 × 4 mm). Methanol (A) and methanol:water (9:1) (B) were
used as the mobile phase. A gradient at a flow rate of 1.5 mL/min was used as the following; 0 min B:
0%, 10 min B: 100%, 32.5 min B: 100%.
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